Motor neuron susceptibility in ALS/FTD
AMG Ragagnin, S Shadfar, M Vidal… - Frontiers in …, 2019 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the
death of both upper and lower motor neurons (MNs) in the brain, brainstem and spinal cord …
death of both upper and lower motor neurons (MNs) in the brain, brainstem and spinal cord …
The “dying-back” phenomenon of motor neurons in ALS
M Dadon-Nachum, E Melamed, D Offen - Journal of molecular …, 2011 - Springer
Amyotrophic lateral sclerosis (ALS) is a lethal disease, characterized by progressive death
of motor neurons with unknown etiology. Evidence from animal models indicates that …
of motor neurons with unknown etiology. Evidence from animal models indicates that …
Neuromuscular junction as an entity of nerve-muscle communication
One of the crucial systems severely affected in several neuromuscular diseases is the loss of
effective connection between muscle and nerve, leading to a pathological non …
effective connection between muscle and nerve, leading to a pathological non …
Skeletal muscle in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS), the major adult-onset motor neuron disease, has been
viewed almost exclusively as a disease of upper and lower motor neurons, with muscle …
viewed almost exclusively as a disease of upper and lower motor neurons, with muscle …
Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS)
Amyotrophic lateral sclerosis (ALS) is a motor neuron disease with an extremely
heterogeneous clinical and genetic phenotype. In our efforts to find therapies for ALS, the …
heterogeneous clinical and genetic phenotype. In our efforts to find therapies for ALS, the …
Intercellular (mis) communication in neurodegenerative disease
GA Garden, AR La Spada - Neuron, 2012 - cell.com
Neurodegenerative diseases have been intensively studied, but a comprehensive
understanding of their pathogenesis remains elusive. An increasing body of evidence …
understanding of their pathogenesis remains elusive. An increasing body of evidence …
Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS
ST Lim, M Airavaara, BK Harvey - Pharmacological Research, 2010 - Elsevier
The clinical manifestation of most diseases of the central nervous system results from
neuronal dysfunction or loss. Diseases such as stroke, epilepsy and neurodegeneration (eg …
neuronal dysfunction or loss. Diseases such as stroke, epilepsy and neurodegeneration (eg …
Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise
CH Duman, L Schlesinger, R Terwilliger… - Behavioural brain …, 2009 - Elsevier
Growth factors in the brain are important to depression and it's treatment and we assessed
the ability of peripherally administered insulin-like growth factor-I (IGF-I) to influence …
the ability of peripherally administered insulin-like growth factor-I (IGF-I) to influence …
Understanding ALS: new therapeutic approaches
A Musarò - The FEBS journal, 2013 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease associated with
motor neuron degeneration, muscle atrophy and paralysis. Although numerous pathological …
motor neuron degeneration, muscle atrophy and paralysis. Although numerous pathological …
Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease associated with
motor neuron degeneration, muscle weakness, paralysis and finally death. The proposed …
motor neuron degeneration, muscle weakness, paralysis and finally death. The proposed …